Engagement of PD-1 decreases T cell activation and cytokine production, indicating its role in immune suppression.
Programmed cell death protein 1 (PD-1) is a critical immune checkpoint that suppresses T cell activation and cytotoxicity, yet its mechanistic role in regulating T cell mechanotransduction remains unclear. Here, we reveal that PD-1 engagement attenuates T cell activation by impairing cytoskeletal force generation and nuclear mechanotransduction in a mechanically defined microenvironment. Using tunable poly(ethylene glycol) (PEG)-based hydrogels that mimic the stiffness of target cells, we show that PD-1 suppresses T cell receptor (TCR)-mediated activation in a stiffness-dependent manner, requiring immobilized ligand presentation. Mechanistically, PD-1 ligation disrupts actin polymerization, reduces traction forces, and prevents nuclear deformation, thereby impairing the nuclear translocation of mechanosensitive transcription factors yes-associated protein (YAP) and nuclear factor 1 of activated T cells (NFAT1). This inhibition is mediated by the dephosphorylation of cofilin, an actin-severing protein that restricts actin assembly and downstream mechanotransduction. Consequently, PD-1 engagement diminishes the cytokine production and effector cytotoxicity of T cells. Pharmacological or genetic restoration of actin polymerization or nuclear transport rescues nuclear YAP/NFAT1 localization and partially restores T cell activation and function. Our findings suggest PD-1 as a mechanical checkpoint that suppresses T cell immunity by dampening cytoskeletal dynamics and nuclear mechanotransduction, offering insights into the biophysical regulation of immune suppression.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: